NCT01535495View on ClinicalTrials.gov

Propranolol for Diabetic Retinopathy

PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Proliferative Diabetic Retinopathy
Interventions
DRUG

Propranolol

Propranolol XL 120mg by mouth once daily

Trial Locations (1)

53705

University of Wisconsin - Madison, Madison

All Listed Sponsors
lead

University of Wisconsin, Madison

OTHER

NCT01535495 - Propranolol for Diabetic Retinopathy | Biotech Hunter | Biotech Hunter